Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes with Diabetic Macular Edema in Protocol T

PURPOSE: Assess associations of 2-year visual acuity (VA) outcomes with VA and optical coherence tomography central subfield thickness (CST) after 12 weeks of anti-vascular endothelial growth factor treatment for diabetic macular edema in DRCR.net Protocol T. DESIGN: Randomized clinical trial. METHO...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Ophthalmol
Auteurs principaux: Bressler, Neil M., Beaulieu, Wesley T., Maguire, Maureen G., Glassman, Adam R., Blinder, Kevin J., Bressler, Susan B., Gonzalez, Victor H., Jampol, Lee M., Melia, Michele, Sun, Jennifer K., Wells, John A.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6648655/
https://ncbi.nlm.nih.gov/pubmed/30077569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2018.07.030
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires